November 1, 2009
By:Kenneth A. Getz
Economic factors and sponsor practices will dramatically alter the investigative site landscape.
 |
November 1, 2009
By:Lisa Henderson
Say so long to a 2009 that basically wore out its welcome. And say hello to increased business opportunities in 2010.
|
October 27, 2009
By:Lisa Henderson
Co-founder of investment firm set to acquire MDS Global Central Labs speaks out about his purchase.
|
October 22, 2009
By:Marissa Shapiro
Why knowing a drug's risk and preparing for a risk evaluation mitigation strategy early on will considerably benefit a drug's development.
|
October 1, 2009
By:Peter O'Donnell
The EU struggles to get over its regulatory hurdles in an effort to further R&D success.
|
October 1, 2009
By:Molly Blake-Michaels
A concise look at this nontraditional approach to clinical studies that explains the how and why of it.
|
October 1, 2009
By:Lisa Henderson
Success and challenges for clinical trials that address these interrelated conditions.
|
October 1, 2009
By:Juliane Carvalho, Ekopimo Ibia
The region and its regulatory agencies try to keep up with the rapidly growing clinical trials market.
|
| 
